-
1
-
-
0345150678
-
Pharmacochemistry Library V. 30
-
Elsevier: Amsterdam, the Netherlands
-
Krause, M.; Stark, H.; Schunack, W.; Leurs, R.; Timmermans, H. Pharmacochemistry library v. 30; The Histamine H3 Receptor: A New Target for New Drugs; Leurs, R.; Timmermans, H. Eds.; Elsevier: Amsterdam, the Netherlands, 1998, pp. 175-196.
-
(1998)
The Histamine H3 Receptor: A New Target For New Drugs
, pp. 175-196
-
-
Krause, M.1
Stark, H.2
Schunack, W.3
Leurs, R.4
Timmermans, H.5
-
2
-
-
6444235896
-
-
Stark, H.; Kathmann, M.; Schlicker, E.; Schunack, W.; Schlegel, B.; Sippl, W. title typecontributorMedicinal chemical and pharmacological aspects of imidazole-containing histamine H3 receptor antagonists/title. Mini-Rev. Med. Chem., 2004, 4, 965-977.
-
(2004)
Mini-Rev. Med. Chem
, vol.4
, pp. 965-977
-
-
Stark, H.1
Kathmann, M.2
Schlicker, E.3
Schunack, W.4
Schlegel, B.5
Sippl, W.6
-
3
-
-
14044275765
-
The histamine H3 receptor: From gene cloning to H3 receptor drugs
-
Leurs, R.; Bakker, R. A.; Timmerman, H.; de Esch, I. J. P. The histamine H3 receptor: from gene cloning to H3 receptor drugs. Nat. Rev. Drug Discov., 2005, 4, 107-120.
-
(2005)
Nat. Rev. Drug Discov
, vol.4
, pp. 107-120
-
-
Leurs, R.1
Bakker, R.A.2
Timmerman, H.3
de Esch, I.J.P.4
-
4
-
-
35748932644
-
Recent advances in drug discovery of histamine H3 antagonist
-
Hudkins, R. L.; Raddatz, R. Recent advances in drug discovery of histamine H3 antagonist. Ann. Rep. Med. Chem., 2008, 42, 49-63.
-
(2008)
Ann. Rep. Med. Chem
, vol.42
, pp. 49-63
-
-
Hudkins, R.L.1
Raddatz, R.2
-
5
-
-
29144437722
-
Histamine H3 receptor antagonists reach out for the clinic
-
Celanire, S.; Wijtmans, M.; Talaga, P.; Leurs, R.; Esch, I. J. P. Histamine H3 receptor antagonists reach out for the clinic. Drug Discov. Today, 2005, 10, 1613-1627.
-
(2005)
Drug Discov. Today
, vol.10
, pp. 1613-1627
-
-
Celanire, S.1
Wijtmans, M.2
Talaga, P.3
Leurs, R.4
Esch, I.J.P.5
-
6
-
-
57349083232
-
Histamine H3 receptor antagonists go to the clinic
-
Sander, K.; Kottke, T.; Stark, H. Histamine H3 receptor antagonists go to the clinic. Biol. Pharm. Bull., 2008, 31, 2163-2181.
-
(2008)
Biol. Pharm. Bull.
, vol.31
, pp. 2163-2181
-
-
Sander, K.1
Kottke, T.2
Stark, H.3
-
7
-
-
77949353387
-
Histamine H3 antagonists for the treatment of cognitive deficits in CNS diseases
-
Raddatz, R.; Tao, M.; Hudkins, R. L. Histamine H3 antagonists for the treatment of cognitive deficits in CNS diseases. Curr. Top. Med. Chem., 2010, 10, 153-169.
-
(2010)
Curr. Top. Med. Chem
, vol.10
, pp. 153-169
-
-
Raddatz, R.1
Tao, M.2
Hudkins, R.L.3
-
8
-
-
50349091819
-
Histamine in the nervous system
-
Haas, H. L.; Sergeeva, O.A.; Selbach, O. Histamine in the nervous system. Physiol. Rev., 2008, 88, 1183-1241.
-
(2008)
Physiol. Rev
, vol.88
, pp. 1183-1241
-
-
Haas, H.L.1
Sergeeva, O.A.2
Selbach, O.3
-
10
-
-
0033051582
-
-
Lovenberg, T.W.; Roland, B. L.; Wilson, S. J. Jiang, X.;Pyati, J.; Huvar, A.; Jackson, M. R.; Erlander, M.G. Cloning and functional expression of the human histamine H3 receptor. Mol. Pharmacol., 1999, 55, 1101-1107.
-
(1999)
, vol.55
, pp. 1101-1107
-
-
Lovenberg, T.W.1
Roland, B.L.2
Wilson, S.J.3
Jiang, X.4
Pyati, J.5
Huvar, A.6
Jackson, M.R.7
Erlander, M.G.8
-
11
-
-
0020587209
-
Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor
-
Arrang, J. M.; Garbarg, M.; Schwartz, J. C. Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature, 1983, 302, 832-837.
-
(1983)
Nature
, vol.302
, pp. 832-837
-
-
Arrang, J.M.1
Garbarg, M.2
Schwartz, J.C.3
-
12
-
-
0023653116
-
Highly potent and selective ligands for histamine H3-receptors
-
Arrang, J. M.; Garbarg, M.; Lancelot, J. C.; Lecomte, J. M.; Pollard, H.; Robba, M.; Schunack, W.; Schwartz, J. C. Highly potent and selective ligands for histamine H3-receptors. Nature, 1987, 327, 117-123.
-
(1987)
Nature
, vol.327
, pp. 117-123
-
-
Arrang, J.M.1
Garbarg, M.2
Lancelot, J.C.3
Lecomte, J.M.4
Pollard, H.5
Robba, M.6
Schunack, W.7
Schwartz, J.C.8
-
13
-
-
0030447212
-
Inhibition of cortical acetylcholine release and cognitive performance by histamine H3 receptor activation in rats
-
Blandina, P.; Giorgetti, M.; Bartolini, L.; Cecchi, M.; Timmerman, H.; Leurs, R.; Pepeu, G.; Giovannini, M. G Inhibition of cortical acetylcholine release and cognitive performance by histamine H3 receptor activation in rats. Br. J. Pharmacol., 1996, 119, 1656-1664.
-
(1996)
Br. J. Pharmacol
, vol.119
, pp. 1656-1664
-
-
Blandina, P.1
Giorgetti, M.2
Bartolini, L.3
Cecchi, M.4
Timmerman, H.5
Leurs, R.6
Pepeu, G.7
Giovannini, M.G.8
-
14
-
-
0026612268
-
Histamine H3: A receptor-mediated inhibition of noradrenaline release in the mouse brain cortex
-
Schlicker, E.; Behling, A.; Lümmen, G.; Göthert, M. Histamine H3: A receptor-mediated inhibition of noradrenaline release in the mouse brain cortex. Naunyn Schmiedebergs Arch. Pharmacol., 1992,345, 489-493.
-
(1992)
Naunyn Schmiedebergs Arch. Pharmacol
, vol.345
, pp. 489-493
-
-
Schlicker, E.1
Behling, A.2
Lümmen, G.3
Göthert, M.4
-
15
-
-
0028325424
-
Modulation of neurotransmitter release via histamine H3 heteroreceptors
-
Schlicker, E.; Malinowska, B.; Kathmann, M.; Gothert, M. Modulation of neurotransmitter release via histamine H3 heteroreceptors. Fund. Clin. Pharmacol., 1994, 8, 128-137.
-
(1994)
Fund. Clin. Pharmacol
, vol.8
, pp. 128-137
-
-
Schlicker, E.1
Malinowska, B.2
Kathmann, M.3
Gothert, M.4
-
16
-
-
0034047202
-
Cloning of rat histamine H3 receptor reveals distinct species pharmacological profiles
-
Lovenberg, T. W.; Pyati, J.; Chang, H.; Wilson, S. J.; Erlander, M. G. Cloning of rat histamine H3 receptor reveals distinct species pharmacological profiles. J. Pharm. Exp. Ther., 2000, 293, 771-778.
-
(2000)
J. Pharm. Exp. Ther
, vol.293
, pp. 771-778
-
-
Lovenberg, T.W.1
Pyati, J.2
Chang, H.3
Wilson, S.J.4
Erlander, M.G.5
-
17
-
-
0037401965
-
Molecular modeling and pharmacological analysis of species-related histamine H3 receptor heterogeneity
-
Yao, B. B.; Hutchins, C. W.; Carr, T. L.; Cassar, S.; Masters, J. N.; Bennani, Y. L.; Esbenshade, T. A.; Hancock, A. A. Molecular modeling and pharmacological analysis of species-related histamine H3 receptor heterogeneity. Neuropharmacology, 2003, 44, 773-786.
-
(2003)
Neuropharmacology
, vol.44
, pp. 773-786
-
-
Yao, B.B.1
Hutchins, C.W.2
Carr, T.L.3
Cassar, S.4
Masters, J.N.5
Bennani, Y.L.6
Esbenshade, T.A.7
Hancock, A.A.8
-
18
-
-
0036282457
-
Molecular cloning and pharmacology of functionally distinct isoforms of the human histamine H3 receptor
-
Wellendorph, P.; Goodman, M. W.; Burstein, E. S.; Nash, N. R.; Brann, M. R.; Weiner, D. M. Molecular cloning and pharmacology of functionally distinct isoforms of the human histamine H3 receptor. Neuropharmacology, 2002, 42, 929-940.
-
(2002)
Neuropharmacology
, vol.42
, pp. 929-940
-
-
Wellendorph, P.1
Goodman, M.W.2
Burstein, E.S.3
Nash, N.R.4
Brann, M.R.5
Weiner, D.M.6
-
19
-
-
0034649481
-
High constitutive activity of native H3 receptors regulates histamine neurons in brain
-
Morisset, S.; Rouleau, A.; Lineau, X.; Gbahou, F.; TardivelLacombe, J.; Stark, H.; Schunack, W.; Ganellin, C.R.; Schwartz, J-C.; Arrang, J-M. High constitutive activity of native H3 receptors regulates histamine neurons in brain. Nature, 2000, 408, 860-864.
-
(2000)
Nature
, vol.408
, pp. 860-864
-
-
Morisset, S.1
Rouleau, A.2
Lineau, X.3
Gbahou, F.4
Tardivellacombe, J.5
Stark, H.6
Schunack, W.7
Ganellin, C.R.8
Schwartz, J-C.9
Arrang, J.-M.10
-
20
-
-
0035200715
-
Constitutive activity of histamine H3 receptors stably expressed in SK-N-MC cells: Display of agonism and inverse agonism by H3 antagonists
-
Wieland, K.; Bongers, G.; Yamamoto, Y.; Hashimoto, T.; Yamatodani, A.; Menge, W. M. B. P.; Timmerman, H.; Lovenberg, T.W.; Leurs, R. Constitutive activity of histamine H3 receptors stably expressed in SK-N-MC cells: display of agonism and inverse agonism by H3 antagonists. J. Pharm. Exp. Ther., 2001, 299, 908-914.
-
(2001)
J. Pharm. Exp. Ther
, vol.299
, pp. 908-914
-
-
Wieland, K.1
Bongers, G.2
Yamamoto, Y.3
Hashimoto, T.4
Yamatodani, A.5
Menge, W.M.B.P.6
Timmerman, H.7
Lovenberg, T.W.8
Leurs, R.9
-
21
-
-
57349094379
-
Design of potent GlyT1 inhibitors: In vitro and in vivo profiles
-
Bridges, T.M.; Williams, R.; Lindsley, C.W. Design of potent GlyT1 inhibitors: in vitro and in vivo profiles. Curr. Opin. Mol. Ther., 2008, 10, 591-604.
-
(2008)
Curr. Opin. Mol. Ther
, vol.10
, pp. 591-604
-
-
Bridges, T.M.1
Williams, R.2
Lindsley, C.W.3
-
22
-
-
29344433472
-
Detailed pharmacological characterization of GT-2331 for the rat histamine H3 receptor
-
Ito, S.; Yoshimoto, R.; Miyamoto, Y.; Mitobe, Y.; Nakamura, T.; Ishihara, A.; MacNeil, D. J.; Kanatani, A.; Tokita, S. Detailed pharmacological characterization of GT-2331 for the rat histamine H3 receptor. Eur. J. Pharmacol., 2006, 529, 40-46.
-
(2006)
Eur. J. Pharmacol
, vol.529
, pp. 40-46
-
-
Ito, S.1
Yoshimoto, R.2
Miyamoto, Y.3
Mitobe, Y.4
Nakamura, T.5
Ishihara, A.6
Macneil, D.J.7
Kanatani, A.8
Tokita, S.9
-
23
-
-
0346100541
-
An efficient multigram synthesis of the potent histamine H3 antagonist GT-2331 and the reassessment of the absolute configuration
-
Liu, H.; Kerdesky, F. A.; Black, L. A.; Fitzgerald, M.; Henry, R.; Esbenshade, T. A.; Hancock, A. A.; Bennani, Y. L. An efficient multigram synthesis of the potent histamine H3 antagonist GT-2331 and the reassessment of the absolute configuration. J. Org. Chem., 2004, 69, 192-194.
-
(2004)
J. Org. Chem
, vol.69
, pp. 192-194
-
-
Liu, H.1
Kerdesky, F.A.2
Black, L.A.3
Fitzgerald, M.4
Henry, R.5
Esbenshade, T.A.6
Hancock, A.A.7
Bennani, Y.L.8
-
24
-
-
0035942507
-
Development of a pharmacophore model for histamine H3 receptor antagonists, using the newly developed molecular modeling program SLATE
-
De Esch, I. J.; Mills, J. E.; Perkins, T. D.; Romeo, G.; Hoffmann, M.; Wieland, K.; Leurs, R.; Menge, W. M.; Nederkoorn, P. H.; Dean, P. M.; Timmerman, H. Development of a pharmacophore model for histamine H3 receptor antagonists, using the newly developed molecular modeling program SLATE. J. Med. Chem., 2001,44, 1666-74.
-
(2001)
J. Med. Chem
, vol.44
, pp. 1666-1674
-
-
de Esch, I.J.1
Mills, J.E.2
Perkins, T.D.3
Romeo, G.4
Hoffmann, M.5
Wieland, K.6
Leurs, R.7
Menge, W.M.8
Nederkoorn, P.H.9
Dean, P.M.10
Timmerman, H.11
-
25
-
-
0037763942
-
Identification of a dual histamine H1/H3 receptor ligand based on the H1 antagonist chlorpheniramine
-
Aslanian, R.; Mutahi, M. W.; Shih, N.-Y.; Piwinski, J. J.; West, R.; Williams, S. M.; She, S.; Wu, R.-L.; Hey, J. A. Identification of a dual histamine H1/H3 receptor ligand based on the H1 antagonist chlorpheniramine. Bioorg. Med. Chem. Lett., 2003, 13, 1959-1961.
-
(2003)
Bioorg. Med. Chem. Lett
, vol.13
, pp. 1959-1961
-
-
Aslanian, R.1
Mutahi, M.W.2
Shih, N.-Y.3
Piwinski, J.J.4
West, R.5
Williams, S.M.6
She, S.7
Wu, R.-L.8
Hey, J.A.9
-
26
-
-
0000217390
-
Turbotoxins A and B, novel diiodotyramine derivatives from the Japanese gastropod Turbo marmorata
-
Xynas, R.; Capon, R. Turbotoxins A and B, novel diiodotyramine derivatives from the Japanese gastropod Turbo marmorata. Aust. J. Chem., 1989, 42, 1427-1433.
-
(1989)
Aust. J. Chem
, vol.42
, pp. 1427-1433
-
-
Xynas, R.1
Capon, R.2
-
27
-
-
33746649764
-
Synthesis and SAR of novel histamine H3 receptor antagonists
-
Jesudason, C. D.; Beavers, L. S.; Cramer, J.W.; Dill, J.; Finley, D. R.; Lindsley, C.W.; Stevens, F. C.; Gadski, R. A.; Oldham, S.W.; Pickard, R.T.; Siedem, C. S.; Sindelar, D.K.; Singh, A.; Watson, B.M.; Hipskind, P.A. Synthesis and SAR of novel histamine H3 receptor antagonists. Bioorg. Med. Chem. Lett., 2006, 16, 3415-3418.
-
(2006)
Bioorg. Med. Chem. Lett
, vol.16
, pp. 3415-3418
-
-
Jesudason, C.D.1
Beavers, L.S.2
Cramer, J.W.3
Dill, J.4
Finley, D.R.5
Lindsley, C.W.6
Stevens, F.C.7
Gadski, R.A.8
Oldham, S.W.9
Pickard, R.T.10
Siedem, C.S.11
Sindelar, D.K.12
Singh, A.13
Watson, B.M.14
Hipskind, P.A.15
-
28
-
-
33644834851
-
The challenge of drug discovery of a GPCR target: Analysis of preclinical pharmacology of histamine H3 antagonists/inverse agonists
-
Hancock, A. A. The challenge of drug discovery of a GPCR target: analysis of preclinical pharmacology of histamine H3 antagonists/inverse agonists. Biochem. Pharmacol., 2006, 71, 1103-1113.
-
(2006)
Biochem. Pharmacol.
, vol.71
, pp. 1103-1113
-
-
Hancock, A.A.1
-
29
-
-
19944428635
-
4-(2-[2-(2(R)-methylpyrrolidin-1-yl)ethyl]benzofuran-5-yl)benzonitrile and related 2-aminoethylbenzofuran H3 receptor antagonists potently enhance cognition and attention
-
Cowart, M.; Faghih, R.; Curtis, M. P.; Gfesser, G. A.; Bennani, Y. L.; Black, L. A.; Pan, L.; Marsh, K. C.; Sullivan, J. P.; Esbenshade, T. A.; Fox, G. B.; Hancock, A. A. 4-(2-[2-(2(R)-methylpyrrolidin-1-yl)ethyl]benzofuran-5-yl)benzonitrile and related 2-aminoethylbenzofuran H3 receptor antagonists potently enhance cognition and attention. J. Med. Chem., 2005, 48, 38-55.
-
(2005)
J. Med. Chem
, vol.48
, pp. 38-55
-
-
Cowart, M.1
Faghih, R.2
Curtis, M.P.3
Gfesser, G.A.4
Bennani, Y.L.5
Black, L.A.6
Pan, L.7
Marsh, K.C.8
Sullivan, J.P.9
Esbenshade, T.A.10
Fox, G.B.11
Hancock, A.A.12
-
30
-
-
20144376337
-
Pharmacological properties of ABT-239 [4-(2-{2 [(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl) benzonitrile]: I. Potent and selective histamine H3 receptor antagonist with druglike properties
-
Esbenshade, T. A.; Fox, G. B.; Krueger, K. M.; Miller, T. R.; Kang, C. H.; Denny, L. I.; Witte, D. G.; Yao, B. B.; Pan, L.; Wetter, J.; Marsh, K.; Bennani, Y. L.; Cowart, M. D.; Sullivan, J.P.; Hancock, A. A. Pharmacological properties of ABT-239 [4-(2-{2 [(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl) benzonitrile]: I. Potent and selective histamine H3 receptor antagonist with druglike properties. J. Pharmacol. Exp. Ther., 2005, 313, 165-175.
-
(2005)
J. Pharmacol. Exp. Ther
, vol.313
, pp. 165-175
-
-
Esbenshade, T.A.1
Fox, G.B.2
Krueger, K.M.3
Miller, T.R.4
Kang, C.H.5
Denny, L.I.6
Witte, D.G.7
Yao, B.B.8
Pan, L.9
Wetter, J.10
Marsh, K.11
Bennani, Y.L.12
Cowart, M.D.13
Sullivan, J.P.14
Hancock, A.A.15
-
31
-
-
33947199306
-
Novel heterocyclic-substituted benzofuran histamine H3 receptor antagonists: In vitro properties, drug-likeness, and behavioral activity
-
Cowart, M.; Gfesser, G. A.; Browman, K.E.; Faghih, R.; Miller, T. R.; Milicic, I.; Baranowski, J. L.; Krueger, K. M.; Witte, D. G.; Molesky, A. L.; Komater, V. A.; Buckley, M. J.; Diaz, G. J.; Gagne, G. D.; Zhou, D.; Deng, X.; Pan, L.; Roberts, E. M.; Diehl, M. S.; Wetter, J. M.; Marsh, K. C.; Fox, G. B.; Brioni, J. D.; Esbenshade, T. A.; Hancock, A. A. Novel heterocyclic-substituted benzofuran histamine H3 receptor antagonists: in vitro properties, drug-likeness, and behavioral activity. Biochem. Pharmacol., 2007, 73, 1243-1255.
-
(2007)
Biochem. Pharmacol
, vol.73
, pp. 1243-1255
-
-
Cowart, M.1
Gfesser, G.A.2
Browman, K.E.3
Faghih, R.4
Miller, T.R.5
Milicic, I.6
Baranowski, J.L.7
Krueger, K.M.8
Witte, D.G.9
Molesky, A.L.10
Komater, V.A.11
Buckley, M.J.12
Diaz, G.J.13
Gagne, G.D.14
Zhou, D.15
Deng, X.16
Pan, L.17
Roberts, E.M.18
Diehl, M.S.19
Wetter, J.M.20
Marsh, K.C.21
Fox, G.B.22
Brioni, J.D.23
Esbenshade, T.A.24
Hancock, A.A.25
more..
-
32
-
-
35848968052
-
Synthesis potency, and in vivo profiles of quinoline containing histamine H3 receptor inverse agonists
-
Altenbach, R. J.; Liu, H.; Banfor, P. N.; Browman, K. E.; Fox, G. B.; Fryer, R. M.; Komater, V. A.; Krueger, K. M.; Marsh, K.; Miller, T. R.; Pan, J. B.; Pan, L.; Sun, M.; Thiffault, C.; Wetter, J.; Zhao, C.; Zhou, D.; Esbenshade, T. A.; Hancock, A. A.; Cowart, M. D. Synthesis, potency, and in vivo profiles of quinoline containing histamine H3 receptor inverse agonists. J. Med. Chem., 2007, 50, 5439-5448.
-
(2007)
J. Med. Chem
, vol.50
, pp. 5439-5448
-
-
Altenbach, R.J.1
Liu, H.2
Banfor, P.N.3
Browman, K.E.4
Fox, G.B.5
Fryer, R.M.6
Komater, V.A.7
Krueger, K.M.8
Marsh, K.9
Miller, T.R.10
Pan, J.B.11
Pan, L.12
Sun, M.13
Thiffault, C.14
Wetter, J.15
Zhao, C.16
Zhou, D.17
Esbenshade, T.A.18
Hancock, A.A.19
Cowart, M.D.20
more..
-
33
-
-
70349083023
-
Modulation of the partition coefficient between octanol and buffer at pH 7.4 and pKa to achieve the optimum balance of blood clearance and volume of distribution for a series of tetrahydropyran histamine type 3 receptor antagonists
-
Hay, T.; Jones, R.; Beaumont, K.; Kemp, M. Modulation of the partition coefficient between octanol and buffer at pH 7.4 and pKa to achieve the optimum balance of blood clearance and volume of distribution for a series of tetrahydropyran histamine type 3 receptor antagonists. Drug Metab. Dispos., 2009, 37, 1864-1870.
-
(2009)
Drug Metab. Dispos
, vol.37
, pp. 1864-1870
-
-
Hay, T.1
Jones, R.2
Beaumont, K.3
Kemp, M.4
-
34
-
-
8744233669
-
Acute wake-promoting actions of JNJ-5207852, a novel, diamine-based H3 antagonist
-
Barbier, A. J.; Berridge, C.; Dugovic, C.; Laposky, A. D.; Wilson, S. J.; Boggs, J.; Aluisio, L.; Lord, B.; Mazur, C.; Pudiak, C. M.; Langlois, X.; Xiao, W.; Apodaca, R.; Carruthers, N. I.; Lovenberg, T. W. Acute wake-promoting actions of JNJ-5207852, a novel, diamine-based H3 antagonist. Br. J. Pharmacol., 2004, 143, 649-661.
-
(2004)
Br. J. Pharmacol
, vol.143
, pp. 649-661
-
-
Barbier, A.J.1
Berridge, C.2
Dugovic, C.3
Laposky, A.D.4
Wilson, S.J.5
Boggs, J.6
Aluisio, L.7
Lord, B.8
Mazur, C.9
Pudiak, C.M.10
Langlois, X.11
Xiao, W.12
Apodaca, R.13
Carruthers, N.I.14
Lovenberg, T.W.15
-
35
-
-
33646369637
-
Recent medicinal chemistry of the histamine H3 receptor
-
Letavic, M. A.; Barbier, A. J.; Dvorak, C. A.; Carruthers, N. I. Recent medicinal chemistry of the histamine H3 receptor. Prog. Med. Chem., 2006, 44, 181-206.
-
(2006)
Prog. Med. Chem
, vol.44
, pp. 181-206
-
-
Letavic, M.A.1
Barbier, A.J.2
Dvorak, C.A.3
Carruthers, N.I.4
-
36
-
-
49449107099
-
Synthesis, structure-activity relationships, and biological profiles of a quinazolinone class of histamine H3 receptor inverse agonists
-
Nagase, T.; Mizutani, T.; Ishikawa, S.; Sekino, E.; Sasaki, T.; Fujimura, T.; Ito, S.; Mitobe, Y.; Miyamoto, Y.; Yoshimoto, R.; Tanaka, T.; Ishihara, A.; Takenaga, N.; Tokita, S.; Fukami, T.; Sato, N. Synthesis, structure-activity relationships, and biological profiles of a quinazolinone class of histamine H3 receptor inverse agonists. J. Med. Chem., 2008, 51, 4780-4789.
-
(2008)
J. Med. Chem
, vol.51
, pp. 4780-4789
-
-
Nagase, T.1
Mizutani, T.2
Ishikawa, S.3
Sekino, E.4
Sasaki, T.5
Fujimura, T.6
Ito, S.7
Mitobe, Y.8
Miyamoto, Y.9
Yoshimoto, R.10
Tanaka, T.11
Ishihara, A.12
Takenaga, N.13
Tokita, S.14
Fukami, T.15
Sato, N.16
-
37
-
-
56249112648
-
Synthesis and evaluation of structurally constrained quinazolinone derivatives as potent and selective histamine H3 receptor inverse agonists
-
Nagase, T.; Mizutani, T.; Sekino, E.; Ishikawa, S.; Ito, S.; Mitobe, Y.; Miyamoto, Y.; Yoshimoto, R.; Tanaka, T.; Ishihara, A.; Takenaga, N.; Tokita, S.; Sato, N. Synthesis and evaluation of structurally constrained quinazolinone derivatives as potent and selective histamine H3 receptor inverse agonists. J. Med. Chem., 2008, 51, 6889-6901.
-
(2008)
J. Med. Chem
, vol.51
, pp. 6889-6901
-
-
Nagase, T.1
Mizutani, T.2
Sekino, E.3
Ishikawa, S.4
Ito, S.5
Mitobe, Y.6
Miyamoto, Y.7
Yoshimoto, R.8
Tanaka, T.9
Ishihara, A.10
Takenaga, N.11
Tokita, S.12
Sato, N.13
-
38
-
-
55549142497
-
Development of novel 2-[4-(aminoalkoxy)phenyl]-4(3H)-quinazolinone derivatives as potent and selective histamine H3 receptor inverse agonists
-
Mizutani, T.; Nagase, T.; Ito, S.; Miyamoto, Y.; Tanaka, T.; Takenaga, N.; Tokita, S.; Sato, N. Development of novel 2-[4-(aminoalkoxy)phenyl]-4(3H)-quinazolinone derivatives as potent and selective histamine H3 receptor inverse agonists. Bioorg. Med. Chem. Lett., 2008, 18, 6041-6045.
-
(2008)
Bioorg. Med. Chem. Lett
, vol.18
, pp. 6041-6045
-
-
Mizutani, T.1
Nagase, T.2
Ito, S.3
Miyamoto, Y.4
Tanaka, T.5
Takenaga, N.6
Tokita, S.7
Sato, N.8
-
39
-
-
67649983981
-
Development of a selective and potent radioactive ligand for histamine H3 receptors: A compound potentially useful for receptor occupancy studies
-
Mitobe, Y.; Ito, S.; Mizutani, T.; Nagase, T.; Sato, N.; Tokita, S. Development of a selective and potent radioactive ligand for histamine H3 receptors: A compound potentially useful for receptor occupancy studies. Bioorg. Med. Chem. Lett., 2009, 19, 4075-4078.
-
(2009)
Bioorg. Med. Chem. Lett
, vol.19
, pp. 4075-4078
-
-
Mitobe, Y.1
Ito, S.2
Mizutani, T.3
Nagase, T.4
Sato, N.5
Tokita, S.6
-
40
-
-
67649977931
-
-
Sasaki, T.; Takahashi, T.; Nagase, T.; Mizutani, T.; Ito, S.; Mitobe, Y.; Miyamoto, Y.; Kanesaka, M.; Yoshimoto, R.; Tanaka, T.; Takenaga, N.; Tokita, S.; Sato, N. title typecontributorSynthesis, structure-activity relationships, and biological profiles of a dihydrobenzoxathiin class of histamine H3 receptor inverse agonists/title. Bioorg. Med. Chem. Lett., 2009,19, 4232-4236.
-
(2009)
Bioorg. Med. Chem. Lett
, vol.19
, pp. 4232-4236
-
-
Sasaki, T.1
Takahashi, T.2
Nagase, T.3
Mizutani, T.4
Ito, S.5
Mitobe, Y.6
Miyamoto, Y.7
Kanesaka, M.8
Yoshimoto, R.9
Tanaka, T.10
Takenaga, N.11
Tokita, S.12
Sato, N.13
-
41
-
-
51349160447
-
Synthesis and evaluation of a spiroisobenzofuranone class of histamine H3 receptor inverse agonists
-
Jitsuoka, M.; Tsukahara, D.; Ito, S.; Tanaka, T.; Takenaga, N.; Tokita, S.; Sato, N. Synthesis and evaluation of a spiroisobenzofuranone class of histamine H3 receptor inverse agonists. Bioorg. Med. Chem. Lett., 2008, 18, 5101-5106.
-
(2008)
Bioorg. Med. Chem. Lett
, vol.18
, pp. 5101-5106
-
-
Jitsuoka, M.1
Tsukahara, D.2
Ito, S.3
Tanaka, T.4
Takenaga, N.5
Tokita, S.6
Sato, N.7
-
42
-
-
70349868406
-
Inverseagonist histamine H3 receptor PET tracers labelled with carbon-11orfluorine-18
-
Hamill, T. G.; Sato, N.; Jitsuoka, M.; Tokita, S.; Sanabria, S.; Eng, W.; Ryan, C.; Krause, S.; Takenaga, N.; Patel, S.; Zeng, Z.; Williams, D. Jr.; Sur, C.; Hargreaves, R.; Burns, H. D. Inverseagonist histamine H3 receptor PET tracers labelled with carbon-11orfluorine-18. Synapse, 2009, 63, 1122-1132.
-
(2009)
Synapse
, vol.63
, pp. 1122-1132
-
-
Hamill, T.G.1
Sato, N.2
Jitsuoka, M.3
Tokita, S.4
Sanabria, S.5
Eng, W.6
Ryan, C.7
Krause, S.8
Takenaga, N.9
Patel, S.10
Zeng, Z.11
Williams Jr., D.12
Sur, C.13
Hargreaves, R.14
Burns, H.D.15
-
43
-
-
34250179519
-
A new class of histamine H3 receptor antagonists derived from ligand based design. Bioorg. Med
-
Roche, O.; Rodríguez, R. M. A new class of histamine H3 receptor antagonists derived from ligand based design. Bioorg. Med. Chem. Lett., 2007, 17, 3670-3675.
-
(2007)
Chem. Lett
, vol.17
, pp. 3670-3675
-
-
Roche, O.1
Rodríguez, R.M.2
-
44
-
-
47749128056
-
Refinement of histamine H3 ligands pharmacophore model leads to a new class of potent and selective naphthalene inverse agonists
-
Roche, O.; Nettekoven, M.; Vifian, W.; Sarmiento, R. M. Refinement of histamine H3 ligands pharmacophore model leads to a new class of potent and selective naphthalene inverse agonists. Bioorg. Med. Chem. Lett., 2008, 18, 4377-4379.
-
(2008)
Bioorg. Med. Chem. Lett
, vol.18
, pp. 4377-4379
-
-
Roche, O.1
Nettekoven, M.2
Vifian, W.3
Sarmiento, R.M.4
-
45
-
-
67649968886
-
Selective naphthalene H3 receptor inverse agonists with reduced potential to induce phospholipidosis and their quinoline analogs
-
Rodríguez Sarmiento, R. M.; Nettekoven, M. H.; Taylor, S.; Plancher, J. M.; Richter, H.; Roche, O. Selective naphthalene H3 receptor inverse agonists with reduced potential to induce phospholipidosis and their quinoline analogs. Bioorg. Med. Chem. Lett., 2009,19, 4495-4500
-
(2009)
Bioorg. Med. Chem. Lett
, vol.19
, pp. 4495-4500
-
-
Rodríguez sarmiento, R.M.1
Nettekoven, M.H.2
Taylor, S.3
Plancher, J.M.4
Richter, H.5
Roche, O.6
-
46
-
-
52949143487
-
The hERG channel and risk of drug-acquired cardiac arrhythmia: An overview
-
Lagrutta, A. A.; Trepakova, E. S.; Salata, J. J. The hERG channel and risk of drug-acquired cardiac arrhythmia: an overview. Curr. Top. Med. Chem., 2008, 8, 1102-1112.
-
(2008)
Curr. Top. Med. Chem
, vol.8
, pp. 1102-1112
-
-
Lagrutta, A.A.1
Trepakova, E.S.2
Salata, J.J.3
-
48
-
-
33947121092
-
Structurally novel histamine H3 receptor antagonists GSK207040 and GSK334429 improve scopolamine-induced memory impairment and capsaicin-induced secondary allodynia in rats
-
Medhurst, A. D.; Briggs, M. A.; Bruton, G.; Calver, A. R.; Chessell, I.; Crook, B.; Davis, J. B.; Davis, R. P.; Foley, A. G.; Heslop, T.; Hirst, W. D.; Medhurst, S. J.; Ociepka, S.; Ray, A.;Regan, C. M.; Sargent, B.; Schogger, J.; Stean, T. O.; Trail, B. K.; Upton, N.; White, T.; Orlek, B.; Wilson, D. M. Structurally novel histamine H3 receptor antagonists GSK207040 and GSK334429 improve scopolamine-induced memory impairment and capsaicin-induced secondary allodynia in rats. Biochem. Pharmacol., 2007, 73, 1182-1194.
-
(2007)
Biochem. Pharmacol
, vol.73
, pp. 1182-1194
-
-
Medhurst, A.D.1
Briggs, M.A.2
Bruton, G.3
Calver, A.R.4
Chessell, I.5
Crook, B.6
Davis, J.B.7
Davis, R.P.8
Foley, A.G.9
Heslop, T.10
Hirst, W.D.11
Medhurst, S.J.12
Ociepka, S.13
Ray, A.14
Regan, C.M.15
Sargent, B.16
Schogger, J.17
Stean, T.O.18
Trail, B.K.19
Upton, N.20
White, T.21
Orlek, B.22
Wilson, D.M.23
more..
-
49
-
-
30344458497
-
Aplysamine1 and related analogs as histamine H3 receptor antagonists
-
Swanson, D. M.; Wilson, S. J.; Boggs, J. D.; Xiao, W.; Apodaca, R.; Barbier, A. J.; Lovenberg, T. W.; Carruthers, N. I. Aplysamine1 and related analogs as histamine H3 receptor antagonists. Bioorg. Med. Chem. Lett., 2006, 16, 897-900.
-
(2006)
Bioorg. Med. Chem. Lett
, vol.16
, pp. 897-900
-
-
Swanson, D.M.1
Wilson, S.J.2
Boggs, J.D.3
Xiao, W.4
Apodaca, R.5
Barbier, A.J.6
Lovenberg, T.W.7
Carruthers, N.I.8
-
50
-
-
0028222730
-
Verongamine, a novel bromotyrosine-derived histamine H3-antagonist from the marine sponge Verongula gigantea
-
Mierzwa, R.; King, A.; Conover, M. A.; Tozzi, S.; Puar, M. S.; Patel, M.; Coval, S. J.; Pomponi, S. A. Verongamine, a novel bromotyrosine-derived histamine H3-antagonist from the marine sponge Verongula gigantea. J. Nat. Prod., 1994, 57, 175-177.
-
(1994)
J. Nat. Prod
, vol.57
, pp. 175-177
-
-
Mierzwa, R.1
King, A.2
Conover, M.A.3
Tozzi, S.4
Puar, M.S.5
Patel, M.6
Coval, S.J.7
Pomponi, S.A.8
-
51
-
-
51849139033
-
The alkaloid conessine and analogues as potent histamine H3 receptor antagonists
-
Zhao, C.; Sun, M.; Bennani, Y. L.; Gopalakrishnan, S. M.; Witte, D. G.; Miller, T. R.; Krueger, K. M.; Browman, K. E.; Thiffault, C.; Wetter, J.; Marsh, K. C.; Hancock, A. A.; Esbenshade, T. A.;Cowart, M. D. The alkaloid conessine and analogues as potent histamine H3 receptor antagonists. J. Med. Chem., 2008, 51, 5423-5430.
-
(2008)
J. Med. Chem
, vol.51
, pp. 5423-5430
-
-
Zhao, C.1
Sun, M.2
Bennani, Y.L.3
Gopalakrishnan, S.M.4
Witte, D.G.5
Miller, T.R.6
Krueger, K.M.7
Browman, K.E.8
Thiffault, C.9
Wetter, J.10
Marsh, K.C.11
Hancock, A.A.12
Esbenshade, T.A.13
Cowart, M.D.14
-
52
-
-
68549132508
-
Design of a new histamine H3 receptor antagonist chemotype: (3aR,6aR)-5-Alkyl-1-aryl-octahydropyrrolo[3,4-b]pyrroles, synthesis, and structure-activity relationships
-
Zhao, C.; Sun, M.; Bennani, Y. L.; Miller, T. R.; Witte, D. G.; Esbenshade, T. A.; Wetter, J.; Marsh, K. C.; Hancock, A. A.; Brioni, J. D.; Cowart, M. D. Design of a new histamine H3 receptor antagonist chemotype: (3aR,6aR)-5-Alkyl-1-aryl-octahydropyrrolo[3,4-b]pyrroles, synthesis, and structure-activity relationships. J. Med. Chem., 2009, 52(15), 4640-4649.
-
(2009)
J. Med. Chem
, vol.52
, Issue.15
, pp. 4640-4649
-
-
Zhao, C.1
Sun, M.2
Bennani, Y.L.3
Miller, T.R.4
Witte, D.G.5
Esbenshade, T.A.6
Wetter, J.7
Marsh, K.C.8
Hancock, A.A.9
Brioni, J.D.10
Cowart, M.D.11
-
53
-
-
38949158070
-
A new family of H3 receptor antagonists based on the natural product Conessine
-
Santora, V. J.; Covel, J. A.; Hayashi, R.; Hofilena, B. J.; Ibarra, J. B.; Pulley, M. D.; Weinhouse, M. I.; Sengupta, D.; Duffield, J. J.; Semple, G.; Webb, R. R.; Sage, C.; Ren, A.; Pereira, G.; Knudsen, J.; Edwards, J. E.; Suarez, M.; Frazer, J.; Thomsen, W.; Hauser, E.; Whelan, K.; Grottick, A. J. A new family of H3 receptor antagonists based on the natural product Conessine. Bioorg. Med. Chem. Lett., 2008, 18, 1490-1494.
-
(2008)
Bioorg. Med. Chem. Lett
, vol.18
, pp. 1490-1494
-
-
Santora, V.J.1
Covel, J.A.2
Hayashi, R.3
Hofilena, B.J.4
Ibarra, J.B.5
Pulley, M.D.6
Weinhouse, M.I.7
Sengupta, D.8
Duffield, J.J.9
Semple, G.10
Webb, R.R.11
Sage, C.12
Ren, A.13
Pereira, G.14
Knudsen, J.15
Edwards, J.E.16
Suarez, M.17
Frazer, J.18
Thomsen, W.19
Hauser, E.20
Whelan, K.21
Grottick, A.J.22
more..
-
54
-
-
47149092037
-
Novel H3 receptor antagonists with improved pharmacokinetic profiles
-
Santora, V. J.; Covel, J. A.; Hayashi, R.; Hofilena, B. J.; Ibarra, J. B.; Pulley, M. D.; Weinhouse, M. I.; Semple, G.; Ren, A.; Pereira, G.; Edwards, J. E.; Suarez, M.; Frazer, J.; Thomsen, W.; Hauser, E.; Lorea, J.; Grottick, A. J. Novel H3 receptor antagonists with improved pharmacokinetic profiles. Bioorg. Med. Chem. Lett., 2008,18, 4133-4136.
-
(2008)
Bioorg. Med. Chem. Lett
, vol.18
, pp. 4133-4136
-
-
Santora, V.J.1
Covel, J.A.2
Hayashi, R.3
Hofilena, B.J.4
Ibarra, J.B.5
Pulley, M.D.6
Weinhouse, M.I.7
Semple, G.8
Ren, A.9
Pereira, G.10
Edwards, J.E.11
Suarez, M.12
Frazer, J.13
Thomsen, W.14
Hauser, E.15
Lorea, J.16
Grottick, A.J.17
-
55
-
-
8744283471
-
Pharmacological effects of carcinine on histaminergic neurons in the brain
-
Chen, Z.; Sakurai, E.; Hu, W.; Jin, C.; Kiso, Y.; Kato, M.; Watanabe, T.; Wei, E.; Yanai, K. Pharmacological effects of carcinine on histaminergic neurons in the brain. Br. J. Pharmacol.,2004, 143, 573-580.
-
(2004)
Br. J. Pharmacol
, vol.143
, pp. 573-580
-
-
Chen, Z.1
Sakurai, E.2
Hu, W.3
Jin, C.4
Kiso, Y.5
Kato, M.6
Watanabe, T.7
Wei, E.8
Yanai, K.9
-
56
-
-
40949124014
-
PF1270A, B and C, novel histamine H3 receptor ligands produced by Penicillium waksmanii PF1270
-
Kushida, N.; Watanabe, N.; Okuda, T.; Yokoyama, F.; Gyobu, Y.; Yaguchi, T.; PF1270A, B and C, novel histamine H3 receptor ligands produced by Penicillium waksmanii PF1270. J. Antibiot.,2007, 60, 667-673.
-
(2007)
J. Antibiot
, vol.60
, pp. 667-673
-
-
Kushida, N.1
Watanabe, N.2
Okuda, T.3
Yokoyama, F.4
Gyobu, Y.5
Yaguchi, T.6
-
57
-
-
56049125024
-
Total synthesis and biological evaluation of the marine bromopyrrole alkaloid dispyrin: Elucidation of discrete molecular targets with therapeutic potential
-
Kennedy, J. P.; Brogan, J. T.; Lindsley, C. W. Total synthesis and biological evaluation of the marine bromopyrrole alkaloid dispyrin: elucidation of discrete molecular targets with therapeutic potential. J. Nat. Prod., 2008, 71, 1783-1788.
-
(2008)
J. Nat. Prod
, vol.71
, pp. 1783-1788
-
-
Kennedy, J.P.1
Brogan, J.T.2
Lindsley, C.W.3
-
58
-
-
34249005543
-
Bromopyrrole carboxamide biosynthetic products from the Caribbean sponge Agelas dispar
-
Piña, I. C.; White, K. N.; Cabrera, G.; Rivero, E.; Crews, P. Bromopyrrole carboxamide biosynthetic products from the Caribbean sponge Agelas dispar. J. Nat. Prod., 2007, 70, 613-617.
-
(2007)
J. Nat. Prod
, vol.70
, pp. 613-617
-
-
Piña, I.C.1
White, K.N.2
Cabrera, G.3
Rivero, E.4
Crews, P.5
-
59
-
-
65749108134
-
A novel class of H3 antagonists derived from the natural product guided synthesis of unnatural analogs of the marine bromopyrrole alkaloid dispyrin
-
Kennedy, J. P.; Conn, P. J.; Lindsley, C. W. A novel class of H3 antagonists derived from the natural product guided synthesis of unnatural analogs of the marine bromopyrrole alkaloid dispyrin Bioorg. Med. Chem. Lett., 2009, 19, 3204-3208.
-
(2009)
Bioorg. Med. Chem. Lett
, vol.19
, pp. 3204-3208
-
-
Kennedy, J.P.1
Conn, P.J.2
Lindsley, C.W.3
-
60
-
-
62749126730
-
Rapid, general access to chiral flouroamines and, -difluoroamines via organocatalysis
-
Fadeyi, O.; Lindsley, C.W. Rapid, general access to chiral flouroamines and, -difluoroamines via organocatalysis. Org. Lett., 2009, 11, 943-946.
-
(2009)
Org. Lett
, vol.11
, pp. 943-946
-
-
Fadeyi, O.1
Lindsley, C.W.2
-
61
-
-
70349778603
-
Heterocyclic replacement of the central phenyl core of diamine-based histamine H3 receptor antagonists
-
Swanson, D. M.; Shah, C.R.; Lord, B.; Morton, K.; Dvorak, L. K.; Mazur, C.; Apodaca, R.; Xiao, W.; Boggs, J. D.; Feinstein, M.; Wilson, S. J.; Barbier, A. J.; Bonaventure, P.; Lovenberg, T. W.; Carruthers, N. I. Heterocyclic replacement of the central phenyl core of diamine-based histamine H3 receptor antagonists. Eur. J. Med. Chem., 2009, 44, 4413-4425.
-
(2009)
Eur. J. Med. Chem
, vol.44
, pp. 4413-4425
-
-
Swanson, D.M.1
Shah, C.R.2
Lord, B.3
Morton, K.4
Dvorak, L.K.5
Mazur, C.6
Apodaca, R.7
Xiao, W.8
Boggs, J.D.9
Feinstein, M.10
Wilson, S.J.11
Barbier, A.J.12
Bonaventure, P.13
Lovenberg, T.W.14
Carruthers, N.I.15
-
62
-
-
76749147279
-
Acidic elements in histamine H3 receptor antagonists
-
Sander, K.; von Coburg, Y.; Camelin, J-C.; Ligneau, X.; Rau, O.; Schubert-Zsilavecz, M.; Schwartz, J-C.; Stark, H. Acidic elements in histamine H3 receptor antagonists. Bioorg. Med. Chem. Lett., 2010,20, 1581-1584.
-
(2010)
Bioorg. Med. Chem. Lett
, vol.20
, pp. 1581-1584
-
-
Sander, K.1
von Coburg, Y.2
Camelin, J.-C.3
Ligneau, X.4
Rau, O.5
Schubert-Zsilavecz, M.6
Schwartz, J.-C.7
Stark, H.8
-
63
-
-
34548583105
-
Dual serotonin transporter inhibitor/histamine H3 antagonists: Development of rigidified H3 pharmacophores
-
Keith, J. M.; Barbier, A. J.; Wilson, S. J.; Miller, K.; Boggs, J. D.; Fraser, I. C.; Mazur, C.; Lovenberg, T. W.; Carruthers, N. I. Dual serotonin transporter inhibitor/histamine H3 antagonists: development of rigidified H3 pharmacophores. Bioorg. Med. Chem. Lett., 2007,17, 5325-5329.
-
(2007)
Bioorg. Med. Chem. Lett
, vol.17
, pp. 5325-5329
-
-
Keith, J.M.1
Barbier, A.J.2
Wilson, S.J.3
Miller, K.4
Boggs, J.D.5
Fraser, I.C.6
Mazur, C.7
Lovenberg, T.W.8
Carruthers, N.I.9
-
64
-
-
37549047997
-
Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors
-
Ly, K. S.; Letavic, M. A.; Keith, J. M.; Miller, J. M.; Stocking, E. M.; Barbier, A. J.; Bonaventure, P.; Lord, B.; Jiang, X.; Boggs, J.D.; Dvorak, L.; Miller, K. L.; Nepomuceno, D.; Wilson, S. J.; Carruthers, N. I. Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors. Bioorg. Med. Chem. Lett., 2008, 18, 39-43.
-
(2008)
Bioorg. Med. Chem. Lett
, vol.18
, pp. 39-43
-
-
Ly, K.S.1
Letavic, M.A.2
Keith, J.M.3
Miller, J.M.4
Stocking, E.M.5
Barbier, A.J.6
Bonaventure, P.7
Lord, B.8
Jiang, X.9
Boggs, J.D.10
Dvorak, L.11
Miller, K.L.12
Nepomuceno, D.13
Wilson, S.J.14
Carruthers, N.I.15
-
65
-
-
34547516889
-
Benzylamine histamine H3 antagonists and serotonin reuptakeinhibitors
-
Letavic, M. A.; Stocking, E. M.; Barbier, A. J.; Bonaventure, P.; Boggs, J. D.; Lord, B.; Miller, K. L.; Wilson, S. J.; Carruthers, N. I. Benzylamine histamine H3 antagonists and serotonin reuptakeinhibitors. Bioorg. Med. Chem. Lett., 2007, 17, 4799-4803.
-
(2007)
Bioorg. Med. Chem. Lett
, vol.17
, pp. 4799-4803
-
-
Letavic, M.A.1
Stocking, E.M.2
Barbier, A.J.3
Bonaventure, P.4
Boggs, J.D.5
Lord, B.6
Miller, K.L.7
Wilson, S.J.8
Carruthers, N.I.9
-
66
-
-
34347380862
-
Pyrrolidino-tetrahydroisoquinolines bearing pendant heterocycles as potent dual H3 antagonist and serotonin transporter inhibitors
-
Keith, J. M.; Gomez, L. A.; Barbier, A. J.; Wilson, S. J.; Boggs, J. D.; Lord, B.; Mazur, C.; Aluisio, L.; Lovenberg, T. W.; Carruthers, N. I. Pyrrolidino-tetrahydroisoquinolines bearing pendant heterocycles as potent dual H3 antagonist and serotonin transporter inhibitors. Bioorg. Med. Chem. Lett., 2007, 17, 4374-4377.
-
(2007)
Bioorg. Med. Chem. Lett
, vol.17
, pp. 4374-4377
-
-
Keith, J.M.1
Gomez, L.A.2
Barbier, A.J.3
Wilson, S.J.4
Boggs, J.D.5
Lord, B.6
Mazur, C.7
Aluisio, L.8
Lovenberg, T.W.9
Carruthers, N.I.10
-
67
-
-
34247857599
-
Synthesis and biological evaluation of diaminebased histamine H3 antagonists with serotonin reuptake inhibitor activity
-
Stocking, E. M.; Miller, J. M.; Barbier, A. J.; Wilson, S. J.; Boggs, J. D.; McAllister, H. M.; Wu, J.; Lovenberg, T. W.; Carruthers, N. I.; Wolin, R. L. Synthesis and biological evaluation of diaminebased histamine H3 antagonists with serotonin reuptake inhibitor activity. Bioorg. Med. Chem. Lett., 2007, 17, 3130-3135.
-
(2007)
Bioorg. Med. Chem. Lett
, vol.17
, pp. 3130-3135
-
-
Stocking, E.M.1
Miller, J.M.2
Barbier, A.J.3
Wilson, S.J.4
Boggs, J.D.5
McAllister, H.M.6
Wu, J.7
Lovenberg, T.W.8
Carruthers, N.I.9
Wolin, R.L.10
-
68
-
-
33947715270
-
Pyrrolidinotetrahydroisoquinolines as potent dual H3 antagonist and serotonin transporter inhibitors
-
Keith, J. M.; Gomez, L. A.; Wolin, R. L.; Barbier, A. J.; Wilson, S. J.; Boggs, J. D.; Mazur, C.; Fraser, I. C.; Lord, B.; Aluisio, L.; Lovenberg, T. W., Carruthers, N. I. Pyrrolidinotetrahydroisoquinolines as potent dual H3 antagonist and serotonin transporter inhibitors. Bioorg. Med. Chem. Lett., 2007, 17, 2603-2607.
-
(2007)
Bioorg. Med. Chem. Lett
, vol.17
, pp. 2603-2607
-
-
Keith, J.M.1
Gomez, L.A.2
Wolin, R.L.3
Barbier, A.J.4
Wilson, S.J.5
Boggs, J.D.6
Mazur, C.7
Fraser, I.C.8
Lord, B.9
Aluisio, L.10
Lovenberg, T.W.11
Carruthers, N.I.12
-
69
-
-
33947731437
-
Novel naphthyridines are histamine H3 antagonists and serotonin reuptake transporter inhibitors
-
Letavic, M. A.; Keith, J. M.; Ly, K. S.; Barbier, A. J.; Boggs, J. D.; Wilson, S. J.; Lord, B.; Lovenberg, T. W.; Carruthers, N. I. Novel naphthyridines are histamine H3 antagonists and serotonin reuptake transporter inhibitors. Bioorg. Med. Chem. Lett., 2007, 17, 2566-2569.
-
(2007)
Bioorg. Med. Chem. Lett
, vol.17
, pp. 2566-2569
-
-
Letavic, M.A.1
Keith, J.M.2
Ly, K.S.3
Barbier, A.J.4
Boggs, J.D.5
Wilson, S.J.6
Lord, B.7
Lovenberg, T.W.8
Carruthers, N.I.9
-
70
-
-
33846618166
-
Novel tetrahydroisoquinolines are histamine H3 antagonists and serotonin reuptake inhibitors
-
Letavic, M. A.; Keith, J. M.; Jablonowski, J. A.; Stocking, E. M.; Gomez, L. A.; Ly, K. S.; Miller, J. M.; Barbier, A. J.; Bonaventure, P.; Boggs, J. D.; Wilson, S. J.; Miller, K. L.; Lord, B.; McAllister, H. M.; Tognarelli, D. J.; Wu, J.; Abad, M. C.; Schubert, C.; Lovenberg, T. W.; Carruthers, N. I. Novel tetrahydroisoquinolines are histamine H3 antagonists and serotonin reuptake inhibitors. Bioorg. Med. Chem. Lett., 2007, 17, 1047-1051.
-
(2007)
Bioorg. Med. Chem. Lett
, vol.17
, pp. 1047-1051
-
-
Letavic, M.A.1
Keith, J.M.2
Jablonowski, J.A.3
Stocking, E.M.4
Gomez, L.A.5
Ly, K.S.6
Miller, J.M.7
Barbier, A.J.8
Bonaventure, P.9
Boggs, J.D.10
Wilson, S.J.11
Miller, K.L.12
Lord, B.13
McAllister, H.M.14
Tognarelli, D.J.15
Wu, J.16
Abad, M.C.17
Schubert, C.18
Lovenberg, T.W.19
Carruthers, N.I.20
more..
-
71
-
-
35348880353
-
Pharmacological characterization of JNJ28583867, a histamine H3 receptor antagonist and serotonin reup-take inhibitor
-
Barbier, A. J.; Aluisio, L.; Lord, B.; Qu, Y.; Wilson, S. J.; Boggs, J. D.; Bonaventure, P.; Miller, K.; Fraser, I.; Dvorak, L.; Pudiak, C.; Dugovic, C.; Shelton, J.; Mazur, C.; Letavic, M. A.; Carruthers, N. I.; Lovenberg, T. W. Pharmacological characterization of JNJ28583867, a histamine H3 receptor antagonist and serotonin reup-take inhibitor. Eur. J. Pharmacol., 2007, 576, 43-54.
-
(2007)
Eur. J. Pharmacol
, vol.576
, pp. 43-54
-
-
Barbier, A.J.1
Aluisio, L.2
Lord, B.3
Qu, Y.4
Wilson, S.J.5
Boggs, J.D.6
Bonaventure, P.7
Miller, K.8
Fraser, I.9
Dvorak, L.10
Pudiak, C.11
Dugovic, C.12
Shelton, J.13
Mazur, C.14
Letavic, M.A.15
Carruthers, N.I.16
Lovenberg, T.W.17
-
72
-
-
37149019944
-
A practical synthesis of enantiopure 7-alkoxy-4-aryltetrahydroisoquinoline, a dual serotonin reuptake inhibitor/ histamine H3 antagonist
-
Deng, X.; Liang, J. T.; Liu, J.; McAllister, H.; Schubert, C.; Mani, N. S. A practical synthesis of enantiopure 7-alkoxy-4-aryltetrahydroisoquinoline, a dual serotonin reuptake inhibitor/ histamine H3 antagonist. Org. Process Res. Dev., 2007, 11, 1043-1050.
-
(2007)
Org. Process Res. Dev
, vol.11
, pp. 1043-1050
-
-
Deng, X.1
Liang, J.T.2
Liu, J.3
McAllister, H.4
Schubert, C.5
Mani, N.S.6
-
73
-
-
57849138847
-
Potential utility of histamine H3 receptor antagonist pharmacophore in antipsychotics
-
von Coburg, Y.; Kottke, T.; Weizel, L.; Ligneau, X.; Stark, H. Potential utility of histamine H3 receptor antagonist pharmacophore in antipsychotics. Bioorg. Med. Chem. Lett., 2009, 19, 538-542.
-
(2009)
Bioorg. Med. Chem. Lett
, vol.19
, pp. 538-542
-
-
von Coburg, Y.1
Kottke, T.2
Weizel, L.3
Ligneau, X.4
Stark, H.5
-
74
-
-
40949160570
-
Lead identification of acetylcholinesterase inhibitors-histamine H3 receptor antagonists from molecular modeling
-
Bembenek, S. D.; Keith, J. M.; Letavic, M. A.; Apodaca, R.; Barbier, A. J.; Dvorak, L.; Aluisio, L.; Miller, K. L.; Lovenberg, T. W.; Carruthers, N. I. Lead identification of acetylcholinesterase inhibitors-histamine H3 receptor antagonists from molecular modeling. Bioorg. Med. Chem., 2008, 16, 2968-2973.
-
(2008)
Bioorg. Med. Chem
, vol.16
, pp. 2968-2973
-
-
Bembenek, S.D.1
Keith, J.M.2
Letavic, M.A.3
Apodaca, R.4
Barbier, A.J.5
Dvorak, L.6
Aluisio, L.7
Miller, K.L.8
Lovenberg, T.W.9
Carruthers, N.I.10
-
75
-
-
55749108689
-
Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity
-
Morini, G.; Comini, M.; Rivara, M.; Rivara, S.; Bordi, F.; Plazzi, P. V.; Flammini, L.; Saccani, F.; Bertoni, S.; Ballabeni, V.; Barocelli, E.; Mor, M. Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity. Bioorg. Med. Chem., 2008, 16, 9911-9924.
-
(2008)
Bioorg. Med. Chem
, vol.16
, pp. 9911-9924
-
-
Morini, G.1
Comini, M.2
Rivara, M.3
Rivara, S.4
Bordi, F.5
Plazzi, P.V.6
Flammini, L.7
Saccani, F.8
Bertoni, S.9
Ballabeni, V.10
Barocelli, E.11
Mor, M.12
-
76
-
-
79952932938
-
Use of dual H3/M2 antagonists in the treatment of cognition deficit disorders
-
US6,906,081
-
Hey, J. A.; Aslanian, R. G. Use of dual H3/M2 antagonists in the treatment of cognition deficit disorders. Schering Plough Corporation. US6,906,081. 2005.
-
(2005)
Schering Plough Corporation
-
-
Hey, J.A.1
Aslanian, R.G.2
-
77
-
-
33645361406
-
Multiple enzyme inhibitions by histamine H3 receptor antagonists as potential procognitive agents
-
Petroianu, G.; Arafat, K.; Sasse, B. C.; Stark, H. Multiple enzyme inhibitions by histamine H3 receptor antagonists as potential procognitive agents. Pharmazie, 2006, 61, 179-182.
-
(2006)
Pharmazie
, vol.61
, pp. 179-182
-
-
Petroianu, G.1
Arafat, K.2
Sasse, B.C.3
Stark, H.4
-
78
-
-
0037186501
-
Development of a new class of nonimidazole histamine H3 receptor ligands with combined inhibitory histamine N-methyltransferase activity
-
Apelt, J.; Ligneau, X.; Pertz, H. H.; Arrang, J.-M.; Ganellin, C. R.; Schwartz, J.-C.; Schunack, W.; Stark, H. Development of a new class of nonimidazole histamine H3 receptor ligands with combined inhibitory histamine N-methyltransferase activity. J. Med. Chem., 2002, 45, 1128-1141.
-
(2002)
J. Med. Chem
, vol.45
, pp. 1128-1141
-
-
Apelt, J.1
Ligneau, X.2
Pertz, H.H.3
Arrang, J.-M.4
Ganellin, C.R.5
Schwartz, J.-C.6
Schunack, W.7
Stark, H.8
-
79
-
-
14244268026
-
Search for histamine H3 receptor antagonists with combined inhibitory potency at N-methyltransferase: Ether derivatives
-
Apelt, J.; Grassmann, S.; Ligneau, X.; Pertz, H. H.; Ganellin, C. R.; Arrang, J. M.; Schwartz, J. C.; Schunack, W.; Stark, H. Search for histamine H3 receptor antagonists with combined inhibitory potency at N-methyltransferase: ether derivatives. Pharmazie, 2005, 60, 97-106.
-
(2005)
Pharmazie
, vol.60
, pp. 97-106
-
-
Apelt, J.1
Grassmann, S.2
Ligneau, X.3
Pertz, H.H.4
Ganellin, C.R.5
Arrang, J.M.6
Schwartz, J.C.7
Schunack, W.8
Stark, H.9
-
80
-
-
0037763942
-
Identification of a dual histamine H1/H3 receptor ligand based on the H1 antagonist chlorpheniramine
-
Aslanian, R.; Mutahi, M. W.; Shih, N-Y.; Piwinski, J. J.; West, R.; Williams, S. M.; She, S.; Wu, R. L.; Hey, J. A. Identification of a dual histamine H1/H3 receptor ligand based on the H1 antagonist chlorpheniramine. Bioorg. Med. Chem. Lett., 2003, 13, 1959-1961.
-
(2003)
Bioorg. Med. Chem. Lett
, vol.13
, pp. 1959-1961
-
-
Aslanian, R.1
Mutahi, M.W.2
Shih, N.-Y.3
Piwinski, J.J.4
West, R.5
Williams, S.M.6
She, S.7
Wu, R.L.8
Hey, J.A.9
-
81
-
-
79952961185
-
-
Single and repeat dose first time in human study for an intranasal H1/H3 dual antagonist in healthy male subjects, Web Site, June 30
-
Single and repeat dose first time in human study for an intranasal H1/H3 dual antagonist in healthy male subjects. NCT00694993. ClinicalTrials.gov, Web Site 2008, June 30.
-
(2008)
NCT00694993
-
-
-
82
-
-
79952943535
-
-
Prous Database
-
Prous Database, GSK-1004723D. Drug Data Rep., 2007, 29, 1000.
-
(2007)
GSK-1004723D. Drug Data Rep
, vol.29
, pp. 1000
-
-
-
83
-
-
77949347703
-
Preclinical pharmacology of the novel oral dual histamine H1 and H3 receptor antagonist GSK835726
-
Ford, A.; Browning C.; Russell, L.; Saunders, K.; Hall, D.; Morrison, V.; Changani, K.; Hodgson, S.; Connor, H.; Clark, K. Preclinical pharmacology of the novel oral dual histamine H1 and H3 receptor antagonist GSK835726. Allergy, 2009, 64(Suppl. 90), 69.
-
(2009)
Allergy
, vol.64
, Issue.SUPPL. 90
, pp. 69
-
-
Ford, A.1
Browning, C.2
Russell, L.3
Saunders, K.4
Hall, D.5
Morrison, V.6
Changani, K.7
Hodgson, S.8
Connor, H.9
Clark, K.10
-
84
-
-
79952928721
-
Centrally active allosteric potentiators of the M4 muscarinic acetylcholine receptor reverse amphetamine-induced hyperlocomotion behavior in rats
-
Brady, A.; Jones, C. K.; Bridges, T. M.; Kennedy, P. J.; Thompson, A. D.; Breininger, M. L.; Gentry, P. R.; Yin, H.; Jadhav, S.B.; Shirey, J.; Conn, P. J.; Lindsley, C.W.Centrally active allosteric potentiators of the M4 muscarinic acetylcholine receptor reverse amphetamine-induced hyperlocomotion behavior in rats. J. Pharm.
-
J. Pharm
-
-
Brady, A.1
Jones, C.K.2
Bridges, T.M.3
Kennedy, P.J.4
Thompson, A.D.5
Breininger, M.L.6
Gentry, P.R.7
Yin, H.8
Jadhav, S.B.9
Shirey, J.10
Conn, P.J.11
Lindsley, C.W.12
-
85
-
-
70349769359
-
4 muscarinic acetylcholine receptor
-
Kennedy, J. P.; Bridges, T. M.; Gentry, P. R.; Brogan, J.T.; Brady, A. E.; Shirey, J. K.; Jones, C. K.; Conn, P. J.; Lindsley, C.W. Synthesis and structure-activity-relationships of allosteric potentiators of the M4 muscarinic acetylcholine receptor. Chem. Med. Chem., 2009,4, 1600-1607.
-
(2009)
Chem. Med. Chem
, vol.4
, pp. 1600-1607
-
-
Kennedy, J.P.1
Bridges, T.M.2
Gentry, P.R.3
Brogan, J.T.4
Brady, A.E.5
Shirey, J.K.6
Jones, C.K.7
Conn, P.J.8
Lindsley, C.W.9
-
87
-
-
33947289522
-
Brain histamine and schizophrenia:Potential therapeutic applications of H3-receptor inverse agonists studied with BF2.649
-
Ligneau, X.; Landais, L.; Perrin, D.; Piriou, J.; Uguen, M.; Denis, E.; Robert, P.; Parmentier, R.; Anaclet, C.; Lin, J. S.; Burban, A.; Arrang, J. M.; Schwartz, J. C. Brain histamine and schizophrenia:potential therapeutic applications of H3-receptor inverse agonists studied with BF2.649. Biochem. Pharmacol., 2007, 73, 1215-1224.
-
(2007)
Biochem. Pharmacol
, vol.73
, pp. 1215-1224
-
-
Ligneau, X.1
Landais, L.2
Perrin, D.3
Piriou, J.4
Uguen, M.5
Denis, E.6
Robert, P.7
Parmentier, R.8
Anaclet, C.9
Lin, J.S.10
Burban, A.11
Arrang, J.M.12
Schwartz, J.C.13
-
88
-
-
40849137722
-
An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: Studies in orexin-/ mice and patients
-
Lin, J. S.; Dauvilliers, Y.; Arnulf, I.; Bastuji, H.; Anaclet, C.; Parmentier, R.; Kocher, L.; Yanagisawa, M.; Lehert, P.; Ligneau, X.; Perrin, D.; Robert, P.; Roux, M.; Lecomte, J. M.; Schwartz, J. C. An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin-/ mice and patients. Neurobiol. Dis., 2008, 30, 74-83.
-
(2008)
Neurobiol. Dis
, vol.30
, pp. 74-83
-
-
Lin, J.S.1
Dauvilliers, Y.2
Arnulf, I.3
Bastuji, H.4
Anaclet, C.5
Parmentier, R.6
Kocher, L.7
Yanagisawa, M.8
Lehert, P.9
Ligneau, X.10
Perrin, D.11
Robert, P.12
Roux, M.13
Lecomte, J.M.14
Schwartz, J.C.15
-
89
-
-
44249085163
-
Correlation between ex vivo receptor occupancy and wakepromoting activity of selective H3 receptor antagonists
-
Le, S.; Gruner, J. A.; Mathiasen, J. R.; Marino, M. J.; Schaffhauser, H. Correlation between ex vivo receptor occupancy and wakepromoting activity of selective H3 receptor antagonists. J. Pharmacol. Exp. Ther., 2008, 325, 902-909.
-
(2008)
J. Pharmacol. Exp. Ther
, vol.325
, pp. 902-909
-
-
Le, S.1
Gruner, J.A.2
Mathiasen, J.R.3
Marino, M.J.4
Schaffhauser, H.5
-
90
-
-
78650776401
-
H3 receptor antagonism increases methylhistamine levels in the cerebrospinal fluid of dogs and healthy human volunteers
-
Vienna, Austria. Abst P1-264, July 11-16
-
Soares, H.; Wager, T. T.; Schmidt, A. W.; Sweeney, F. J.; McLellan, T. J.; Nelson, F. R.; Spracklin, D.; Wang, E. Q.; Faessel, H.; Pinter, G. W.; Li, X.; Chappell, P. B. H3 receptor antagonism increases methylhistamine levels in the cerebrospinal fluid of dogs and healthy human volunteers. International conference on alzheimer ́s disease and related disorders, Vienna, Austria. Abst P1-264, July 11-16, 2009.
-
(2009)
International Conference On Alzheimer ́s Disease and Related Disorders
-
-
Soares, H.1
Wager, T.T.2
Schmidt, A.W.3
Sweeney, F.J.4
McLellan, T.J.5
Nelson, F.R.6
Spracklin, D.7
Wang, E.Q.8
Faessel, H.9
Pinter, G.W.10
Li, X.11
Chappell, P.B.12
|